Abstract
In this paper the authors deal with the main imaging techniques available to clinical cardiologists, with a brief overview of biophysical and biological aspects which are of relevance for the assessment of health effects related to the exposure of patients to both ionizing and non ionizing radiation. A main contribute is the reviewing published evidence on biological effects of radiation, trying to compose a balanced issue in order to increase awareness and knowledge about radiation exposure from cardiac imaging and implications for health risk.
Keywords: Cardiac imaging, biological effects, ionizing radiation, non-ionizing radiation
Current Pharmaceutical Design
Title: The Biological Effects of Diagnostic Cardiac Imaging
Volume: 15 Issue: 10
Author(s): L. Landini, A. Ripoli, M. F. Santarelli, L. Landini Jr. and V. Positano
Affiliation:
Keywords: Cardiac imaging, biological effects, ionizing radiation, non-ionizing radiation
Abstract: In this paper the authors deal with the main imaging techniques available to clinical cardiologists, with a brief overview of biophysical and biological aspects which are of relevance for the assessment of health effects related to the exposure of patients to both ionizing and non ionizing radiation. A main contribute is the reviewing published evidence on biological effects of radiation, trying to compose a balanced issue in order to increase awareness and knowledge about radiation exposure from cardiac imaging and implications for health risk.
Export Options
About this article
Cite this article as:
Landini L., Ripoli A., Santarelli F. M., Landini Jr. L. and Positano V., The Biological Effects of Diagnostic Cardiac Imaging, Current Pharmaceutical Design 2009; 15 (10) . https://dx.doi.org/10.2174/138161209787846919
DOI https://dx.doi.org/10.2174/138161209787846919 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets Adjuvant and Neoadjuvant Chemotherapy for Soft Tissue Sarcomas
Current Medicinal Chemistry Nebulizer Therapy in Pulmonology: Review of the Literature
Current Respiratory Medicine Reviews Pharmacogenomic Approaches to Osteoporosis: 2005 Update
Current Pharmacogenomics Adverse Reactions Induced by Minocycline: A Review of Literature
Current Drug Safety Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Inflammatory Cytokines, Growth Factors, and Depression
Current Pharmaceutical Design Nutrition and NSCLC; Should We Administer Food Supplements?
Current Pharmaceutical Design Subject Index To Volume 12
Current Pharmaceutical Design Drug Targets in Herpes Simplex and Epstein Barr Virus Infections
Infectious Disorders - Drug Targets Personalizing Medicine in Nigeria by Tailoring the Research Process: Points to Consider for Genomic Research
Current Pharmacogenomics and Personalized Medicine Treatment of Epileptic Encephalopathies
Current Pharmaceutical Design Biomarkers and Osteosarcoma and IGF
Recent Patents on Biomarkers Infertility, Pregnancy Loss and Adverse Birth Outcomes in Relation to Maternal Secondhand Tobacco Smoke Exposure
Current Women`s Health Reviews Development of Patents and Clinical Trials on Regenerative Therapy: Gene Therapy
Recent Patents on Regenerative Medicine Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets Epigenetics in Alzheimers Disease: a Focus on DNA Modifications
Current Pharmaceutical Design Impact of Metabolic Surgery on Type-2 Diabetes Remission
Current Diabetes Reviews Social Determinants of Childhood Obesity: Beyond Individual Choices
Current Pediatric Reviews Fibrinogen: A Predictor of Vascular Disease
Current Pharmaceutical Design